AV-380 Archives - Aveo Oncology

A Phase 1b Dose Escalation Study of AV-380 (Anti-GDF15 Monoclonal Antibody) in Combination with Standard-of-Care Therapy in Cancer Patients with Cachexia

Posted on May 29, 2025 (June 11, 2025) by michael

A Phase 1b Dose Escalation Study of AV-380 (Anti-GDF15 Monoclonal Antibody) in Combination with Standard-of-Care Therapy in Cancer Patients with Cachexia

CCS 2023: A phase 1b dose escalation study of AV-380 in combination with standard of care chemotherapy in metastatic cancer patients with cachexia and elevated GDF-15 levels

Posted on September 28, 2023 (December 10, 2024) by michael

CCS 2023: A phase 1b dose escalation study of AV-380 in combination with standard of care chemotherapy in metastatic cancer patients with cachexia and elevated GDF-15 levels